Skip to main content
Premium Trial:

Request an Annual Quote

Sony, Maven Reach Consumables Development Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sony DADC and Maven Biotechnologies announced Wednesday a collaboration to develop and manufacture smart consumables for Maven's platform for performing cell-based assays and multiplexed biomarker detection.

Maven received a $1.96 million grant from the National Institute for Allergy and Infectious Disease in 2010 to commercialize the platform called Label-Free Internal Reflection Ellipsometry.

"The collaboration with Maven provides a perfect example of how we can translate our experience in micro-structured engineering, gained through our pioneering optical disc work, to the needs of the life sciences industry," Ali Tinazli, Sony DADC's director of business development and sales for North America, said in a statement.

Financial and other terms of the deal were not disclosed.

The deal is Sony DADC's fourth in recent months in the life science tools space. Last week, it announced a development deal with Anagnostics, and during the summer it reached agreements with Quanterix and RainDance Technologies.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.